Exercise Capacity in Children and Adolescents With Congenital Heart Disease: A Systematic Review and Meta-Analysis.

cardiopulmonary exercise test congenital malformations heart defects oxygen consumption pediatrics six-minute walking test

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 12 02 2022
accepted: 29 03 2022
entrez: 23 5 2022
pubmed: 24 5 2022
medline: 24 5 2022
Statut: epublish

Résumé

Congenital heart disease (CHD) entails structural defects in the morphogenesis of the heart or its main vessels. Analyzing exercise capacity of children and adolescents with CHD is important to improve their functional condition and quality of life, since it can allow timely intervention on poor prognostic factors associated with higher risk of morbidity and mortality. To describe exercise capacity in children and adolescents with CHD compared with healthy controls. A systematic review was carried out. Randomized clinical trials and observational studies were included assessing exercise capacity through direct and indirect methods in children and adolescents between 5 and 17 years-old. A sensitive analysis was performed including studies with CHD repaired participants. Additionally, it was sub-analyzed by age range (< and ≥ 12 years old). Two independent reviewers analyzed the studies, extracted the data, and assessed the quality of the evidence. 5619 articles were found and 21 were considered for the review. Eighteen articles used the direct exercise capacity measurement method by cardiopulmonary exercise test (CPET). The CHD group showed significant differences in peak oxygen consumption (VO Suffering CHD in childhood and adolescence is associated with lower exercise capacity as shown by worse VO www.crd.york.ac.uk/prospero/display_record.php?RecordID=208963, identifier: CRD42020208963.

Sections du résumé

Background UNASSIGNED
Congenital heart disease (CHD) entails structural defects in the morphogenesis of the heart or its main vessels. Analyzing exercise capacity of children and adolescents with CHD is important to improve their functional condition and quality of life, since it can allow timely intervention on poor prognostic factors associated with higher risk of morbidity and mortality.
Objective UNASSIGNED
To describe exercise capacity in children and adolescents with CHD compared with healthy controls.
Methods UNASSIGNED
A systematic review was carried out. Randomized clinical trials and observational studies were included assessing exercise capacity through direct and indirect methods in children and adolescents between 5 and 17 years-old. A sensitive analysis was performed including studies with CHD repaired participants. Additionally, it was sub-analyzed by age range (< and ≥ 12 years old). Two independent reviewers analyzed the studies, extracted the data, and assessed the quality of the evidence.
Results UNASSIGNED
5619 articles were found and 21 were considered for the review. Eighteen articles used the direct exercise capacity measurement method by cardiopulmonary exercise test (CPET). The CHD group showed significant differences in peak oxygen consumption (VO
Conclusion UNASSIGNED
Suffering CHD in childhood and adolescence is associated with lower exercise capacity as shown by worse VO
Systematic Review Registration UNASSIGNED
www.crd.york.ac.uk/prospero/display_record.php?RecordID=208963, identifier: CRD42020208963.

Identifiants

pubmed: 35600470
doi: 10.3389/fcvm.2022.874700
pmc: PMC9114479
doi:

Types de publication

Systematic Review

Langues

eng

Pagination

874700

Informations de copyright

Copyright © 2022 Villaseca-Rojas, Varela-Melo, Torres-Castro, Vasconcello-Castillo, Mazzucco, Vilaró and Blanco.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Ann Am Thorac Soc. 2017 Jul;14(Supplement_1):S123-S128
pubmed: 28398090
Chest. 1997 Jan;111(1):23-9
pubmed: 8995988
Acta Paediatr. 2002;91(1):65-70
pubmed: 11883822
J Am Coll Cardiol. 2009 Apr 28;53(17):1548-55
pubmed: 19389567
Congenit Heart Dis. 2011 Jul-Aug;6(4):294-303
pubmed: 21418537
Expert Rev Cardiovasc Ther. 2017 Dec;15(12):945-951
pubmed: 28949265
Arch Dis Child. 1990 Aug;65(8):865-70
pubmed: 2400223
Eur Heart J. 2009 Dec;30(23):2915-20
pubmed: 19692392
Med Clin North Am. 2020 Mar;104(2):189-198
pubmed: 32035563
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Int J Cardiol. 2014 Jun 15;174(2):337-42
pubmed: 24768399
Int J Sports Med. 2005 Nov;26(9):756-62
pubmed: 16237621
Circulation. 2014 Aug 26;130(9):749-56
pubmed: 24944314
Int J Epidemiol. 2019 Apr 1;48(2):455-463
pubmed: 30783674
Int J Cardiol. 2018 Mar 15;255:50-54
pubmed: 29425566
Congenit Heart Dis. 2016 Mar-Apr;11(2):155-9
pubmed: 26556777
Arch Dis Child. 2020 Dec;105(12):1167-1174
pubmed: 32732318
Am J Cardiol. 2010 Feb 1;105(3):398-403
pubmed: 20102956
J Am Coll Cardiol. 1992 Jan;19(1):154-8
pubmed: 1729327
Am J Dis Child. 1991 Nov;145(11):1290-3
pubmed: 1951223
Am J Cardiol. 2007 May 15;99(10):1462-7
pubmed: 17493481
Cardiol J. 2009;16(2):133-41
pubmed: 19387960
Catheter Cardiovasc Interv. 2009 Mar 1;73(4):564-7
pubmed: 19133677
ISRN Pediatr. 2012;2012:324306
pubmed: 22973523
Pediatr Exerc Sci. 2015 Aug;27(3):412-8
pubmed: 26186706
Cardiol Young. 2000 May;10(3):201-7
pubmed: 10824899
Kurume Med J. 1994;41(2):97-107
pubmed: 7967444
Pediatr Rev. 2017 Oct;38(10):471-486
pubmed: 28972050
Medicine (Baltimore). 2016 Feb;95(8):e2619
pubmed: 26937900
Int J Cardiol. 2020 May 1;306:168-174
pubmed: 32147225
Dev Med Child Neurol. 2021 Jan;63(1):29-46
pubmed: 32149404
Acta Paediatr. 2020 Dec;109(12):2479-2490
pubmed: 32654285
Arch Pediatr Adolesc Med. 2005 Nov;159(11):1063-8
pubmed: 16275798
Eur J Cardiothorac Surg. 2013 Jun;43(6):1096-100
pubmed: 23345176
J Am Heart Assoc. 2016 Jun 16;5(6):
pubmed: 27312802
PLoS One. 2020 Dec 18;15(12):e0244312
pubmed: 33338081
Appl Physiol Nutr Metab. 2008 Jun;33(3):434-40
pubmed: 18461095
Pediatr Cardiol. 2021 Feb;42(2):408-416
pubmed: 33190162
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Eur Respir Rev. 2021 Apr 29;30(160):
pubmed: 33927006
Arch Pediatr Adolesc Med. 2005 May;159(5):477-81
pubmed: 15867123
Scand Cardiovasc J. 2002 Mar;36(2):80-5
pubmed: 12028869
Eur J Prev Cardiol. 2014 Oct;21(10):1200-15
pubmed: 23787793
Pediatr Cardiol. 2015 Dec;36(8):1573-81
pubmed: 25981567
Heart. 2018 Jun;104(12):1026-1036
pubmed: 29170358
Circ Heart Fail. 2012 Sep 1;5(5):579-85
pubmed: 22773109
Arch Med Sci. 2010 Apr 30;6(2):192-7
pubmed: 22371746
J Card Fail. 2017 Nov;23(11):777-782
pubmed: 28736291
Arq Bras Cardiol. 2017 Oct;109(4):357-367
pubmed: 28876372
Am J Cardiol. 2008 Oct 15;102(8):1079-84
pubmed: 18929713

Auteurs

Yenny Villaseca-Rojas (Y)

Programa de Magíster en Fisiología Clínica del Ejercicio, Facultad de Ciencias, Universidad Mayor, Santiago, Chile.
Servicio de Kinesiología, Unidad de Medicina Física y Rehabilitación, Hospital Clínico UC-CHRISTUS, Santiago, Chile.

Javiera Varela-Melo (J)

Programa de Magíster en Fisiología Clínica del Ejercicio, Facultad de Ciencias, Universidad Mayor, Santiago, Chile.
Servicio de Kinesiología, Unidad de Medicina Física y Rehabilitación, Hospital Clínico UC-CHRISTUS, Santiago, Chile.

Rodrigo Torres-Castro (R)

Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile.
International Physiotherapy Research Network (PhysioEvidence), Barcelona, Spain.
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Luis Vasconcello-Castillo (L)

Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile.
International Physiotherapy Research Network (PhysioEvidence), Barcelona, Spain.

Guillermo Mazzucco (G)

Instituto Cardiovascular de Rosario, Rosario, Argentina.
Universidad del Gran Rosario, Rosario, Argentina.

Jordi Vilaró (J)

International Physiotherapy Research Network (PhysioEvidence), Barcelona, Spain.
Blanquerna School of Health Sciences, Global Research on Wellbeing (GRoW), Universitat Ramon Llull, Barcelona, Spain.

Isabel Blanco (I)

Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Department of Pulmonary Medicine, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Center on Respiratory Diseases (CIBERES), Madrid, Spain.

Classifications MeSH